The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1880-4233
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer ; day:29 ; month:6 ; year:2020 ; pages:1-8
Breast cancer ; (29.6.2020), 1-8
- Creator
-
Tajiri, Wakako
Ijichi, Hideki
Takizawa, Katsumi
Koi, Yumiko
Masuda, Takanobu
Ueo, Hiroki
Koga, Chinami
Nakamura, Yoshiaki
Taguchi, Kenichi
Okamoto, Masahiro
Tokunaga, Eriko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12282-020-01130-y
- URN
-
urn:nbn:de:101:1-2020082421155514788743
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tajiri, Wakako
- Ijichi, Hideki
- Takizawa, Katsumi
- Koi, Yumiko
- Masuda, Takanobu
- Ueo, Hiroki
- Koga, Chinami
- Nakamura, Yoshiaki
- Taguchi, Kenichi
- Okamoto, Masahiro
- Tokunaga, Eriko
- SpringerLink (Online service)
Other Objects (12)
The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis
The usefulness of experiments
Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
Punishing Wrongs from the Distant Past
Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer
Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy-Naïve Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer in the UK
Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
The therapeutic challenge in postmenopausal hypertension
Endocrine Function of the Postmenopausal Ovary
The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis
The usefulness of experiments
Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
Punishing Wrongs from the Distant Past
Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer
Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy-Naïve Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer in the UK
Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
The therapeutic challenge in postmenopausal hypertension
Endocrine Function of the Postmenopausal Ovary
The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis
The usefulness of experiments
Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
Punishing Wrongs from the Distant Past
Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer
Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy-Naïve Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer in the UK
Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
The therapeutic challenge in postmenopausal hypertension